Elixinol, an Australian based hemp derived CBD company with manufacturing facilities in the United States, has launched the first ever Cannabidiol (CBD) based ad campaign to promote its products in Japan. The first ad was placed in Tokyo’s Omotesando train station.
The new ad is promoting Elixinol’s hemp derived CBD tinctures and their product is being promoted in Japan as a nutritional product with superior antioxidant qualities and health benefits. The company currently sells hemp derived CBD capsules, tinctures, raw oils, topical, and per treats in multiple countries around the world.
Under Japanse federal law Cannabidiol oil is only legal when it is extracted from the non-psychoactive industrial hemp plant and with much convincing Elixinol is the first company to gain advertising approval in the country.
Japan allowing Elixinol to promote their CBD products throughout the country indicates that the international community is starting to approve of CBD oil for its medicinal properties. The allowance of marketing campaigns surrounding CBD products also shows the value of these product as a commercial commodity.
“Approval to commercially advertise our Hemp Oil Drops is a major win for the hemp industry and comes after many months of working with the relevant authorities to gain authorization,” said Makoto Matsumaru, CEO of Elixinol Japan.
You may be interested
Featured CCT Interview with CEO of Eden Labs AC BraddockEditor - August 20, 2018
Eden Labs LLC. has been developing and providing plant based extraction equipment out of Seattle, Washington for some of the largest and most respected companies involved in…
VividGro, a Pegasus Capital Advisors Portfolio Company, Announces Partnership with Merida Capital PartnersEditor - August 17, 2018
Partnership to Focus on Growth in Horticultural and Cannabis Industries VividGro, LLC, a portfolio company of private equity firm Pegasus Capital Advisors (Pegasus), today announced it has…
Harborside to Go Public Via Canadian Reverse Takeover in Deal Valued at C$200 MillionEditor - August 15, 2018
Harborside, a California based cannabis dispensary brand with multiple locations, is planning the reverse takeover of Canadian public company Lineage Grow Company Ltd. (CSE: BUDD). Lineage is…